GATC Health

Register Now: https://lnkd.in/giumkV7i

DIA Webinar on May 28th The New Standard for ROI: Using Predictive AI to Insure & De-Risk Biotech Investments We are proud to announce that GATC Health’s Chief Business Officer, V. Tyrone Lam, will moderate this essential industry conversation. He will be joined by a panel of thought leaders, including our own Mark Flather, SVP of Business Development and Strategy. Featured Panelists: Dave Pfeiffer – SVP, Head of ARCAS, Biotech Erica Horwitz – Managing Director, Healthcare, RBC Capital Markets Mark Flather – SVP, Business Development and Strategy, GATC Health Register Now: https://lnkd.in/giumkV7i

GATC Health is proud to share an op-ed published in BioSpace, co-authored by our President, Dr. Rahul Gupta, alongside our esteemed advisors and collaborators: Chad Beyer, GATC Health Advisor Fred Brown, GATC Health Advisor  Drew Gupta, Resident Physician in Radiation Oncology (Harvard MD, Yale BS) Visit our Website to learn more about GATC Health:  https://gatchealth.com/ Read the full article in BioSpace: https://lnkd.in/de25e4G5

Last week at #FierceBiotechWeek in Boston, GATC Health President Dr. Rahul Gupta took the stage to share how our proprietary Operon™ platform and Derisq™ AI Report are accelerating drug discovery and de-risking assets. Dr. Rahul Gupta shared these insights during a distinguished panel focused on the realities of scaling AI across the biopharma enterprise. We were proud to drive this critical conversation alongside fellow industry leaders Daniel Haders II, Ph.D. (Model Medicines) and Alexander Pickett (Juvenescence®) for such an impactful conversation, expertly moderated by @Melina Fan (Addgene). Learn more about how GATC Health is leading this transformation here: https://lnkd.in/gJ8BXZdX #FierceBiotechWeek #AIinBiopharma #GATCHealth #Operon #Derisq #DrugDiscovery

GATC Health is discovering new treatments for opioid use disorder. At the 2026 NDASA Conference, our Chief Business Officer, V. Tyrone Lam was invited onstage by Stephen Loyd, MD, West Virginia's Director of Drug Policy and one of the most respected voices in addiction medicine in the country, to discuss GATC Health’s potential breakthrough in the support of those suffering from opioid use disorder. GATC-1021, GATC Health’s drug candidate as a potential treatment for opioid use disorder, was identified using GATC Health’s Operon™ AI platform to more precisely target the specific neurological dysregulations found in individuals with Opioid Use Disorder (OUD). PNAS: https://lnkd.in/gYfxz6n8 Fierce Biotech: https://lnkd.in/gnAdFeGG Drug Discovery News: https://lnkd.in/ggiir_Tz GATC Health Operon™ Platform: https://lnkd.in/gJ8BXZdX #GATCHealth #Operon #Derisq #DrugDiscovery #OpioidUseDisorder WVU Innovation Corporation

Stephen Loyd, MD is a force of nature and a National treasure when it comes to talking about his journey and addiction recovery—recasting the mold on how medicines and other therapies are used to combat SUDs! Keep up the great work Dr Loyd and GATC Health!

Last week, GATC Health President Dr. Rahul Gupta spoke to BiotechTV at the Convergence Forum to discuss how we’re using AI to: 1️⃣ Accelerate Drug Discovery 2️⃣ Derisq Assets Learn more about Derisq: https://lnkd.in/gG3uYfU4 Get in touch: https://lnkd.in/gA_XF9bB

Last month GATC Health Drug Discovery Lead, Alexa C. Martin, Ph.D., was in Washington, D.C. for the "Hope on the Horizon" event, hosted by Scientific American and the WVU Rockefeller Neuroscience Institute. Alexa C. Martin, Ph.D. and Stephen Loyd, MD had a chance to chat about the future of addiction medicine and the momentum behind GATC-1021, GATC Health’s drug candidate as a potential treatment for opioid use disorder. PNAS: https://lnkd.in/gYfxz6n8 Fierce Biotech: https://lnkd.in/gnAdFeGG Drug Discovery News: https://lnkd.in/ggiir_Tz GATC Health Operon™ Platform: https://lnkd.in/gJ8BXZdX #GATCHealth #Operon #Derisq #DrugDiscovery #OpioidUseDisorder WVU Innovation Corporation

GATC Health President, Dr. Rahul Gupta, will be a featured speaker at #FierceBiotech week in Boston this morning. Panel: Scaling AI Across the Biopharma Enterprise 📅 Thursday, May 14 | 09:15 AM - 09:55 AM 📍 Picasso 1&2

We are proud to announce that GATC Health President, Dr. Rahul Gupta, will be a featured speaker at #FierceBiotech week in Boston this Thursday. Drawing on his distinguished career—including his tenure as Director of National Drug Control Policy—Dr. Rahul Gupta will share insights on how AI is being scaled across the Biopharma Enterprise. At GATC Health, we are leading this transformation through our proprietary Operon™ platform, learn more here: https://lnkd.in/gJ8BXZdX Panel: Scaling AI Across the Biopharma Enterprise 📅 Thursday, May 14 | 09:15 AM - 09:55 AM 📍 Picasso 1&2 Moderator: Melina Fan (Addgene) Panelists: Rahul Gupta (GATC Health) Daniel Haders II, Ph.D. II (Model Medicines) Alexander Pickett (Juvenescence®) If you are attending #FierceBiotech in Boston, we invite you to connect with Dr. Rahul Gupta after the session to learn how Operon™ is redefining what is possible in drug discovery. #FierceBiotech #AIinBiopharma #DrugDevelopment #GATCHealth #Operon #Derisq